WG
TGTX icon

Winton Group’s TG Therapeutics TGTX Stock Holding History

Winton Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$861K Sell
15,677
-21,146
-57% -$865K 0.03% 546
2026
Q1 		$1.22M Buy
36,823
+11,581
+46% +$345K 0.04% 473
2025
Q4 		$752K Sell
25,242
-99,758
-80% -$3.26M 0.03% 549
2025
Q3 		$4.52M Buy
125,000
+113,951
+1,031% +$3.75M 0.17% 186
2025
Q2 		$398K Sell
11,049
-21,025
-66% -$783K 0.02% 641
2025
Q1 		$1.26M Sell
32,074
-8,362
-21% -$281K 0.08% 252
2024
Q4 		$1.22M Sell
40,436
-4,645
-10% -$133K 0.08% 224
2024
Q3 		$1.05M Buy
+45,081
New +$985K 0.07% 290
2023
Q2 		– Sell
-23,961
Closed -$360K – 1102
2023
Q1 		$360K Buy
23,961
+92
+0.4% +$1.4K 0.02% 780
2022
Q4 		$282K Buy
23,869
+883
+4% +$6.41K 0.02% 798
2022
Q3 		$136K Sell
22,986
-2,729
-11% -$17.9K 0.01% 890
2022
Q2 		$109K Buy
25,715
+5,943
+30% +$37.1K 0.01% 921
2022
Q1 		$188K Buy
19,772
+3,985
+25% +$46.1K 0.01% 915
2021
Q4 		$300K Buy
15,787
+9,108
+136% +$236K 0.02% 833
2021
Q3 		$222K Sell
6,679
-9,517
-59% -$294K 0.01% 1205
2021
Q2 		$628K Buy
16,196
+8,816
+119% +$346K 0.03% 790
2021
Q1 		$356K Buy
+7,380
New +$355K 0.02% 1063

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Winton Group's TGTX Position: Q2 2026 in Review

Winton Group reduced its TG Therapeutics (TGTX) stake by 57% in Q2 2026, selling an estimated $865K and leaving 15,677 shares worth $861K. The position accounts for 0.03% of the portfolio, ranked #546.

Winton Group first reported a position in TGTX in Q1 2021 and has held it in 17 quarters since. The position peaked at $4.52M in Q3 2025. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Winton Group held 15,677 shares of TG Therapeutics worth $861K as of Q2 2026.
  • Winton Group sold 21,146 TG Therapeutics shares in Q2 2026, an estimated $865K.
  • TG Therapeutics made up 0.03% of Winton Group's portfolio in Q2 2026, its #546 holding.
  • Winton Group first reported a position in TG Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • Winton Group's TG Therapeutics position peaked at $4.52M in Q3 2025.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.